Eveline Annette van de Stadt

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients

Imke H. Bartelink, Eveline Annette van de Stadt, Anke F. Leeuwerik et al. · Pharmaceuticals · 2022 · 25 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +16

Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging

Eveline Annette van de Stadt, Maqsood Yaqub, Adriaan A. Lammertsma et al. · Lung Cancer · 2021 · 15 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients

Eveline Annette van de Stadt, Maqsood Yaqub, Robert C. Schuit et al. · Diagnostics · 2022 · 15 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +16

Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study

Eveline Annette van de Stadt, Maqsood Yaqub, Adriaan A. Lammertsma et al. · EJNMMI Research · 2020 · 12 citations · Full text

Medicine, Nuclear Medicine, Oncology +13